1496552-16-9Relevant articles and documents
Preparation method of anti-HCV medicine
-
, (2021/06/13)
The invention relates to the technical field of medical intermediates, in particular to a preparation method of an anti-HCV drug, which comprises the following steps: 1) reacting a compound I with a compound II in the presence of Lewis acid and alkali to obtain a compound III; and 2) reacting the compound III with a compound IV to obtain a compound V. The method effectively solves the problems of tedious steps, difficulty in purification, high cost and the like in the prior art. Meanwhile, the whole route is mild in reaction condition, convenient to operate, high in yield and purity and suitable for industrial large-scale production.
Method for preparing sofosbuvir
-
Paragraph 0029-0042; 0073-0077; 0079-0082, (2020/04/22)
The invention discloses a method for preparing sofosbuvir. The method comprises the following steps: reacting tetrahydrofuran with a tetrahydrofuran solution of a material A, a material B, DMAP and ananiline compound under the protection of nitrogen, and monitoring the reaction by TLC until the reaction of the material A is finished, wherein the aniline compound is N,N-dimethylaniline or N,N-diethylaniline; and carrying out post-treatment on the obtained reaction product. The method for preparing sofosbuvir has the advantages of high reaction efficiency, high product yield (up to 90% or above), high purity (up to 98% or above), easiness in industrial large-scale production and great application values.
Method for synthesizing Sofosbuvir
-
Paragraph 0030-0067, (2020/04/17)
The invention discloses a method for synthesizing Sofosbuvir. The method comprises the steps of adding a compound 1, a compound 2 and dichloromethane into a reaction bulb, cooling the temperature to 0DEG C, then, adding aluminum chloride, adding a proper amount of pyridine, and carrying out a reaction at a reaction temperature of 15 DEG C to 20 DEG C, thereby producing the Sofosbuvir. According to the method, the reaction is high in conversion ratio and good in regioselectivity and stereoselectivity, so that the synthesis cost of the Sofosbuvir is reduced, and the method has remarkable socialand economic benefits.